CGC
CGC
NASDAQ · Pharmaceuticals

Canopy Growth Corp

$0.68
-0.08 (-10.11%)
As of Nov 6, 2:11 PM ET ·
Financial Highlights (FY 2026)
Revenue
577.58M
Net Income
-533,544,390
Gross Margin
27.9%
Profit Margin
-92.4%
Rev Growth
-10.9%
D/E Ratio
0.35
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 27.9% 27.9% 56.1% 56.1%
Operating Margin -61.9% -55.7% 13.1% 13.7%
Profit Margin -92.4% -87.8% 14.3% 14.3%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 577.58M 648.53M 156.52M 143.27M
Gross Profit 161.43M 181.26M 87.74M 80.31M
Operating Income -357,694,044 -361,469,390 20.57M 19.56M
Net Income -533,544,390 -539,175,781 22.40M 20.41M
Gross Margin 27.9% 27.9% 56.1% 56.1%
Operating Margin -61.9% -55.7% 13.1% 13.7%
Profit Margin -92.4% -87.8% 14.3% 14.3%
Rev Growth -10.9% -10.9% +1.7% +0.2%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 52.39M 52.39M 105.38M 93.00M
Total Equity 148.58M 148.58M 454.44M 415.12M
D/E Ratio 0.35 0.35 0.23 0.22
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -317,428,972 -338,600,408 28.04M 26.75M
Free Cash Flow — — 15.05M 13.14M